Immuneering Corp Stock Buy Hold or Sell Recommendation
| IMRX Stock | USD 2.08 0.02 0.95% |
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Immuneering Corp is 'Strong Sell'. A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Immuneering Corp given historical horizon and risk tolerance towards Immuneering Corp. When Macroaxis issues a 'buy' or 'sell' recommendation for Immuneering Corp, the advice is generated through an automated system that utilizes algorithms and statistical models.
Check out Immuneering Corp Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. For more information on how to buy Immuneering Stock please use our How to Invest in Immuneering Corp guide. In addition, we conduct extensive research on individual companies such as Immuneering and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards Immuneering Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
Immuneering |
Execute Immuneering Corp Buy or Sell Advice
The Immuneering recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Immuneering Corp. Macroaxis does not own or have any residual interests in Immuneering Corp or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Immuneering Corp's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | OK | Details | |
Volatility | Very risky | Details | |
Hype Condition | Over hyped | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Below Average | Details | |
Economic Sensitivity | Almost mirrors the market | Details | |
Investor Sentiment | Impartial | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Strenth (F Score) | Frail | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Possible Manipulator | Details |
Immuneering Corp Trading Alerts and Improvement Suggestions
| Immuneering Corp is way too risky over 90 days horizon | |
| Immuneering Corp appears to be risky and price may revert if volatility continues | |
| The company reported the previous year's revenue of 455. Net Loss for the year was (53.47 M) with profit before overhead, payroll, taxes, and interest of 158.83 K. | |
| Immuneering Corp currently holds about 128.1 M in cash with (48.97 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.85, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Immuneering Corp has a frail financial position based on the latest SEC disclosures | |
| Roughly 29.0% of the company shares are held by company insiders | |
| Latest headline from news.google.com: Immuneering Co. Given Consensus Recommendation of Moderate Buy by Brokerages - MarketBeat |
Immuneering Corp Returns Distribution Density
The distribution of Immuneering Corp's historical returns is an attempt to chart the uncertainty of Immuneering Corp's future price movements. The chart of the probability distribution of Immuneering Corp daily returns describes the distribution of returns around its average expected value. We use Immuneering Corp price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Immuneering Corp returns is essential to provide solid investment advice for Immuneering Corp.
| Mean Return | 1.50 | Value At Risk | -8.68 | Potential Upside | 15.50 | Standard Deviation | 10.20 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Immuneering Corp historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Immuneering Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument, such as Immuneering Corp, soars without any apparent reason? This usually happens because many institutional investors are aggressively trading Immuneering Corp back and forth among themselves.
| Shares | Morgan Stanley - Brokerage Accounts | 2024-06-30 | 92.1 K | Susquehanna International Group, Llp | 2024-06-30 | 88.8 K | Manufacturers Life Insurance Co | 2024-09-30 | 82.6 K | Exchange Traded Concepts, Llc | 2024-06-30 | 74.9 K | Jane Street Group Llc | 2024-06-30 | 74.8 K | State Street Corp | 2024-06-30 | 69.2 K | Tidemark Llc | 2024-09-30 | 51.9 K | Hightower Advisors, Llc | 2024-06-30 | 44 K | Ci Private Wealth Llc | 2024-06-30 | 43.4 K | Vanguard Group Inc | 2024-09-30 | 1.1 M | Millennium Management Llc | 2024-06-30 | 953.2 K |
Immuneering Corp Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Immuneering Corp or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Immuneering Corp's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Immuneering stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | 1.37 | |
β | Beta against Dow Jones | 1.06 | |
σ | Overall volatility | 10.38 | |
Ir | Information ratio | 0.13 |
Immuneering Corp Volatility Alert
Immuneering Corp is displaying above-average volatility over the selected time horizon. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Immuneering Corp's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Immuneering Corp's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Immuneering Corp Fundamentals Vs Peers
Comparing Immuneering Corp's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Immuneering Corp's direct or indirect competition across all of the common fundamentals between Immuneering Corp and the related equities. This way, we can detect undervalued stocks with similar characteristics as Immuneering Corp or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Immuneering Corp's fundamental indicators could also be used in its relative valuation, which is a method of valuing Immuneering Corp by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Immuneering Corp to competition |
| Fundamentals | Immuneering Corp | Peer Average |
| Return On Equity | -0.62 | -0.31 |
| Return On Asset | -0.37 | -0.14 |
| Current Valuation | 18.79 M | 16.62 B |
| Shares Outstanding | 31.05 M | 571.82 M |
| Shares Owned By Insiders | 29.12 % | 10.09 % |
| Shares Owned By Institutions | 30.11 % | 39.21 % |
| Number Of Shares Shorted | 2.05 M | 4.71 M |
| Price To Book | 1.13 X | 9.51 X |
| Price To Sales | 563.62 X | 11.42 X |
| Revenue | 455 | 9.43 B |
| Gross Profit | 158.83 K | 27.38 B |
| EBITDA | (58.06 M) | 3.9 B |
| Net Income | (53.47 M) | 570.98 M |
| Cash And Equivalents | 128.1 M | 2.7 B |
| Cash Per Share | 4.85 X | 5.01 X |
| Total Debt | 4.46 M | 5.32 B |
| Debt To Equity | 0.04 % | 48.70 % |
| Current Ratio | 33.99 X | 2.16 X |
| Book Value Per Share | 3.09 X | 1.93 K |
| Cash Flow From Operations | (48.97 M) | 971.22 M |
| Short Ratio | 1.19 X | 4.00 X |
| Earnings Per Share | (1.97) X | 3.12 X |
| Target Price | 11.21 | |
| Number Of Employees | 66 | 18.84 K |
| Beta | -0.4 | -0.15 |
| Market Capitalization | 65.21 M | 19.03 B |
| Total Asset | 102.58 M | 29.47 B |
| Retained Earnings | (163.26 M) | 9.33 B |
| Working Capital | 81.24 M | 1.48 B |
| Net Asset | 102.58 M |
Note: Disposition of 60500 shares by Leah Neufeld of Immuneering Corp at 6.09 subject to Rule 16b-3 [view details]
Immuneering Corp Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Immuneering . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 15844.72 | |||
| Daily Balance Of Power | (0.17) | |||
| Rate Of Daily Change | 0.99 | |||
| Day Median Price | 2.1 | |||
| Day Typical Price | 2.09 | |||
| Price Action Indicator | (0.03) | |||
| Period Momentum Indicator | (0.02) |
About Immuneering Corp Buy or Sell Advice
When is the right time to buy or sell Immuneering Corp? Buying financial instruments such as Immuneering Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Immuneering Corp in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Defense Thematic Idea Now
Defense
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Defense theme has 16 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Defense Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Immuneering Stock Analysis
When running Immuneering Corp's price analysis, check to measure Immuneering Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immuneering Corp is operating at the current time. Most of Immuneering Corp's value examination focuses on studying past and present price action to predict the probability of Immuneering Corp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Immuneering Corp's price. Additionally, you may evaluate how the addition of Immuneering Corp to your portfolios can decrease your overall portfolio volatility.